SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells, University of Texas MD Anderson Cancer Center Reveals
April 12, 2011
 · 
1 min read
Lone Star Bio
Blueberries May Inhibit Development of Fat Cells, Texas Woman’s University Study
April 11, 2011
 · 
1 min read
Lone Star Bio
Dangerous Blood Pressure Increases During Exercise Can be Blocked, UT Southwestern Medical Center Study
April 5, 2011
 · 
1 min read
Lone Star Bio
Potential New Non-Insulin Treatment for Type 1 Diabetes Found, UT Southwestern Medical Center Study Reveals
March 25, 2011
 · 
3 min read
Lone Star Bio
Nanomaterial Bulks Up Under Stress, Rice University Study Reveals
March 24, 2011
 · 
1 min read
Lone Star Bio
Menthol Cigarette Less Likely to Cause Lung Cancer? - Vanderbilt University and Meharry Medical College Study Reveals
March 24, 2011
 · 
1 min read
Lone Star Bio
Drug Prevents Type 2 Diabetes in Majority of High-Risk Individuals, Pennington Biomedical Research Center Study Finds
March 24, 2011
 · 
1 min read
Lone Star Bio
Transistor Performance Improves Due to Quantum Confinement Effects, University of Texas Study
March 22, 2011
 · 
1 min read
Lone Star Bio
Stem Cell Therapy Shrinks Enlarged Hearts, University of Miami Study
March 18, 2011
 · 
4 min read
Lone Star Bio
‘Pruned’ Microchips are Faster, Smaller, More Energy-Efficient, Rice University and Nanyang Technological University Study
March 17, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
January 9, 2026
 · 
3 min read
Press Releases
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
January 9, 2026
 · 
5 min read
Press Releases
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
 · 
4 min read
Press Releases
Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
January 9, 2026
 · 
6 min read
Press Releases
Surf Therapeutics Announces Early Feasibility Study (EFS) To Advance Non-Invasive Approach to Neuromodulation for Rheumatoid Arthritis
January 9, 2026
 · 
3 min read
Press Releases
Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
January 9, 2026
 · 
4 min read
Press Releases
L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale
January 8, 2026
 · 
1 min read
Press Releases
Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients
January 8, 2026
 · 
8 min read
Press Releases
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
January 8, 2026
 · 
6 min read
Press Releases
Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases
January 8, 2026
 · 
7 min read
Load More